scispace - formally typeset
Search or ask a question
Institution

University of Texas System

EducationAustin, Texas, United States
About: University of Texas System is a education organization based out in Austin, Texas, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 13901 authors who have published 10925 publications receiving 319328 citations. The organization is also known as: UT System.
Topics: Cancer, Population, Antigen, Gene, Antibody


Papers
More filters
Journal ArticleDOI
TL;DR: Melatonin administration to nicotine-treated rats attenuated the increase in LPO products and restored the SOD activity and GSH levels, suggesting that melatonin may be useful in combating free radical-induced oxidative stress and tissue injury that is a result of nicotine toxicity.

78 citations

Patent
30 Apr 2009
Abstract: The present invention includes an integrated system and methods for patient treatment, the system includes a hospital bed; a plurality of patient diagnostic and treatment devices connected to a network, wherein each of the devices can communicate to a network and exchange information with the network about the care of a patient; and a processor accessible adjacent to the bed and connected to the network to integrate information obtained from the devices through the network with one or more additional sources of information databases, wherein the processor can communicate to one or more patient treatment devices either directly or via the network and the processor directs the one or more patient treatment devices to change the treatment of the patient.

78 citations

Journal ArticleDOI
30 Oct 2015-PLOS ONE
TL;DR: The findings provide little evidence for benefits of diet diversity for either abdominal obesity or diabetes and do not support the notion that “eating everything in moderation” leads to greater diet quality or better metabolic health.
Abstract: Diet guidelines recommend increasing dietary diversity. Yet, metrics for dietary diversity have neither been well-defined nor evaluated for impact on metabolic health. Also, whether diversity has effects independent of diet quality is unknown. We characterized and evaluated associations of diet diversity and quality with abdominal obesity and type II diabetes (T2D) in the Multi-Ethnic Study of Atherosclerosis. At baseline (2000–02), diet was assessed among 5,160 Whites, Hispanic, Blacks, and Chinese age 45–84 y and free of T2D, using a validated questionnaire. Three different aspects of diet diversity were characterized including count (number of different food items eaten more than once/week, a broad measure of diversity), evenness (Berry index, a measure of the spread of the diversity), and dissimilarity (Jaccard distance, a measure of the diversity of the attributes of the foods consumed). Diet quality was characterized using aHEI, DASH, and a priori pattern. Count and evenness were weakly positively correlated with diet quality (r with AHEI: 0.20, 0.04), while dissimilarity was moderately inversely correlated (r = -0.34). In multivariate models, neither count nor evenness was associated with change in waist circumference (WC) or incident T2D. Greater food dissimilarity was associated with higher gain in WC (p-trend<0.01), with 120% higher gain in participants in the highest quintile of dissimilarity scores. Diet diversity was not associated with incident T2D. Also, none of the diversity metrics were associated with change in WC or incident T2D when restricted to only healthier or less healthy foods. Higher diet quality was associated with lower risk of T2D. Our findings provide little evidence for benefits of diet diversity for either abdominal obesity or diabetes. Greater dissimilarity among foods was actually associated with gain in WC. These results do not support the notion that “eating everything in moderation” leads to greater diet quality or better metabolic health.

78 citations

Journal ArticleDOI
TL;DR: In this paper, the myostatin null (MSTN)-deficient mice were subjected to two different forms of training, namely wheel running and swimming, and compared the response at morphological, myocellular and molecular levels.
Abstract: Myostatin regulates both muscle mass and muscle metabolism. The myostatin null (MSTN(-/-)) mouse has a hypermuscular phenotype owing to both hypertrophy and hyperplasia of the myofibres. The enlarged muscles display a reliance on glycolysis for energy production; however, enlarged muscles that develop in the absence of myostatin have compromised force-generating capacity. Recent evidence has suggested that endurance exercise training increases the oxidative properties of muscle. Here, we aimed to identify key changes in the muscle phenotype of MSTN(-/-) mice that can be induced by training. To this end, we subjected MSTN(-/-) mice to two different forms of training, namely voluntary wheel running and swimming, and compared the response at the morphological, myocellular and molecular levels. We found that both regimes normalized changes of myostatin deficiency and restored muscle function. We showed that both exercise training regimes increased muscle capillary density and the expression of Ucp3, Cpt1α, Pdk4 and Errγ, key markers for oxidative metabolism. Cross-sectional area of hypertrophic myofibres from MSTN(-/-) mice decreased towards wild-type values in response to exercise and, in this context, Bnip3, a key autophagy-related gene, was upregulated. This reduction in myofibre size caused an increase of the nuclear-to-cytoplasmic ratio towards wild-type values. Importantly, both training regimes increased muscle force in MSTN(-/-) mice. We conclude that impaired skeletal muscle function in myostatin-deficient mice can be improved through endurance exercise-mediated remodelling of muscle fibre size and metabolic profile.

78 citations

Patent
23 May 1995
TL;DR: In this paper, the authors proposed a method for detecting and quantitatively measuring analytes down to the nanomolar range, where anti-analyte antibody molecules are expressed on the surface of a bacterial cell and then used to bind with labeled analyte.
Abstract: The invention relates to novel competitive immunoassays that are useful in detecting and quantitatively measuring analytes down to the nanomolar range. The invention also includes methods of selecting antibodies from libraries of polypeptides expressed on a cell surface. In conducting immunoassays, anti-analyte antibody molecules are expressed on the surface of a bacterial cell and then used to bind with labeled analyte. Quantitation is performed by competitively displacing the bound labeled analyte with a known amount of analyte and measuring the label. The method is rapid and inexpensive and may be performed with readily available safe labeling reagents such as fluorescent compounds.

78 citations


Authors

Showing all 13902 results

NameH-indexPapersCitations
Yi Chen2174342293080
Joseph L. Goldstein207556149527
Eric N. Olson206814144586
Hagop M. Kantarjian2043708210208
Thomas C. Südhof191653118007
Gordon B. Mills1871273186451
Michael S. Brown185422123723
Eric Boerwinkle1831321170971
Russel J. Reiter1691646121010
John D. Minna169951106363
Timothy A. Springer167669122421
Gabriel N. Hortobagyi1661374104845
Rodney S. Ruoff164666194902
Ralph A. DeFronzo160759132993
Ronald A. DePinho160486104039
Network Information
Related Institutions (5)
Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

87% related

National Institutes of Health
297.8K papers, 21.3M citations

87% related

University of Texas Southwestern Medical Center
75.2K papers, 4.4M citations

87% related

University of Pittsburgh
201K papers, 9.6M citations

87% related

University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

87% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20222
2021123
2020197
2019239
2018248
2017290